版本:
中国

BRIEF-Spark Therapeutics reports Q1 loss per share $1.70

May 9 Spark Therapeutics Inc:

* Spark therapeutics reports first quarter 2017 financial results and recent business progress

* Q1 loss per share $1.70

* Q1 earnings per share view $-1.26 -- thomson reuters I/B/E/S

* Spark Therapeutics Inc - plan to provide an initial update on phase 1/2 trial for SPK-8011 in hemophilia a in July or August 2017

* Qtrly revenues $ 1.27 million versus $ 1.29 million Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐